In 1925, Soviet scientist Sergei Brukhonenko developed world's first heart-lung machine 'Autojector' - The remarkable milestone that changed the future of heart surgery

Modern heart surgery saves millions of lives every year, but many people don't realize that one of its earliest breakthroughs dates back more than a century. In 1925, Soviet physiologist Sergei Brukhonenko introduced the 'Autojector', a pioneering heart-lung machine designed to circulate and oxygenate blood outside the body. Although primitive by today's standards, the invention marked one of the first serious attempts to keep organs supplied with oxygen while the heart and lungs were temporarily bypassed.

At a time when open-heart surgery was considered nearly impossible, Brukhonenko's work challenged conventional medical thinking and opened the door to future innovations. While later researchers refined and improved the technology, historians widely recognize the 'Autojector' as a milestone in the long journey toward modern cardiac surgery, proving that life-support machines could one day make once-impossible operations a reality.

A BOLD IDEA DECADES AHEAD OF ITS TIME


In the early 20th century, surgeons faced a major obstacle: operating directly on the human heart was almost impossible because blood circulation would stop if the heart was opened. Doctors needed a way to keep oxygen-rich blood flowing throughout the body while surgery was performed. Brukhonenko, a Soviet biomedical scientist and technologist specializing in circulation and blood transfusion, believed this challenge could be solved mechanically. Working with colleague Sergei Chechulin, he designed the Autojector, a machine capable of pumping blood through an external circuit while adding oxygen before returning it to the body. The concept was revolutionary. Instead of relying solely on the body's heart and lungs, Brukhonenko proposed that a machine could temporarily perform both functions - an idea that would later become the foundation of cardiopulmonary bypass. Brukhonenko famously demonstrated the device by keeping the severed head of a canine alive. The isolated head responded to auditory stimuli, blinked at light, and exhibited basic reflexes.

THE AUTOJECTOR DEMONSTRATED A NEW POSSIBILITY

In collaboration with surgeon Nikolay Terebinsky, Brukhonenko conducted a series of animal experiments, primarily on dogs, to evaluate the machine's ability to maintain blood circulation. Their research suggested that the Autojector could sustain oxygenated blood flow for extended periods under controlled laboratory conditions. Some of these demonstrations were documented in the Soviet scientific film 'Experiments in the Revival of Organisms', released in 1940. The footage showed isolated animal organs responding after circulation had been restored, attracting worldwide attention and sparking debate among scientists about the future of resuscitation and artificial circulation. Although Bryukhonenko never used his heart-lung machine in clinical practice, as reported by PubMed, his pioneering invention became the foundation for later research. Between 1929 and 1940, surgeon Terebinsky applied the concept in a series of experimental open-heart procedures on animals, advancing the field of cardiac surgery. Despite receiving limited recognition during his lifetime, Bryukhonenko's groundbreaking work - together with Terebinsky's contributions - helped establish the scientific basis for the development of cardiac surgery in the Soviet Union and influenced future advances in artificial circulation technology.

RESEARCH THAT PAVED THE WAY FOR MODERN HEART SURGERY

Brukhonenko's work inspired later generations of cardiovascular researchers who sought to build safer and more reliable heart-lung machines. One of the most influential figures was American surgeon Dr. John H Gibbon Jr. After years of research, Gibbon successfully performed the world's first open-heart surgery using a practical heart-lung machine in 1953. His achievement demonstrated that patients could safely undergo complex heart procedures while an external machine temporarily maintained circulation and oxygenation. Medical historians note that Gibbon's success was built upon decades of earlier experimental work by scientists around the world, including Brukhonenko. Although the Autojector was not suitable for routine clinical use, it helped prove that artificial circulation was scientifically possible. Research published over the years in cardiovascular history journals has consistently recognized Brukhonenko as one of the pioneers of extracorporeal circulation.

BRUKHONENKO'S LEGACY STILL LIVES ON

Although Sergei Brukhonenko's name is less familiar than many other medical pioneers, his contribution remains an important chapter in the history of medicine. His willingness to explore an idea that seemed impossible in the 1920s helped reshape scientific thinking about artificial life support. The Autojector demonstrated that machines could sustain blood circulation outside the body - a concept that eventually led not only to safer open-heart surgery but also to technologies such as extracorporeal membrane oxygenation (ECMO), advanced organ preservation systems, and modern life-support devices used in intensive care units. Medical innovation rarely comes from a single invention. Instead, it grows through decades of experimentation, refinement, and collaboration. Brukhonenko's Autojector represents one of those foundational breakthroughs that made future discoveries possible.

Nearly 100 years after its creation, the Autojector stands as a powerful reminder that bold scientific ideas can reshape medicine. What began as an experimental machine in a Soviet laboratory ultimately helped inspire technologies that have saved countless lives, making Brukhonenko one of the overlooked pioneers whose vision helped change the future of heart surgery forever.